Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Single Arm Study Evaluating The Extension From Weekly To Once Every Other Week Darbepoetin Alfa Administration In Subjects With Chronic Kidney Disease Receiving Dialysis.

NCT00436995 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00436995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00436995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Single Arm Study Evaluating The Extension From Weekly To Once Every Other Week Darbepoetin Alfa Administration In Subjects With Chronic Kidney Disease Receiving Dialysis.
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2006
Completion date
December 31, 2008
Enrollment
114 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease